![]() |
Á¶Àç¿ë / CHO, Jae Yong Department / Institute / Center : |
Phone | 82-2-2019-4363 | chojy@yuhs.ac | Website |
---|
Undergraduate Education | M.D., Yonsei University College of Medicine, 1990 |
---|---|
Final Degree (University, Major) | Ph.D., Graduate School, Yonsei University, 1997 |
Overseas Training (Institute, Supervisor) | Dept. of Systems biology, Div of Cancer medicine UT MD Anderson Cancer Center, Houston, Texas, USA Ju-Seog Lee, PhD, 2007-2009 |
´ëÇÑÇ׾Ͽä¹ý¿¬±¸È¸, À§¾ÏºÐ°ú Ãѹ«, 2010-ÇöÀç AACR (American association for cancer research) 2007-ÇöÀç ASCO (American society of clinical oncology) 2000-ÇöÀç |
Translational research, Clinical research, Drug trial |
Research Field | Identification of target for anticancer treatment Development of predictive biomarker for target agent Identification of prognostic biomarker of cancer Biomarker-driven personalized anticancer therapy |
---|---|
Diseases | cancer, gastric cancer, hepatoma, pancreato-biliary tract cancer |
Possible Collaboration | Cancer Genomics( gene expression, microRNA expression, methylation, µî) microRNA systems biology bioinformatics |
Microarray ( gene expression, methylation ) Quatitative RT-PCR microRNA technique Bioinformatics Development of target therapy |
Location of Office | °³²¼¼ºê¶õ½ºº´¿ø º°°ü 7Ãþ ±³¼ö½Ç |
---|---|
Location of Lab. | ÀÇ»ý¸í¿¬±¸¼¾ÅÍ 4Ãþ |
Contact person | Name: ÀÓÀçÀ±(ÀÇÇаú ¹Ú»ç°úÁ¤) / Tel: : 2019-4362 / E-mail: imjy96@yuhs.ac |
1) Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res. 2011 in press 2) Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One. 2010 Nov 30;5(11):e15074. 3) Outcome of adjuvant therapy in gall bladder cancer. Oncology 2010 dec 79 168-173 4) A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer. Annals of oncology 2004, 15:1344-1347 |